Zymergen $125 Million Securities Class Action Settlement

Zymergen $125 Million Securities Class Action SettlementInvestors who bought Zymergen stock in its April 2021 IPO may be eligible to claim a cash payment from a class action settlement.Zymergen $125 Million Securities Class Action SettlementWeekly NewsletterClass actions settlements delivered to your inbox.Thank you! Check your inbox for a welcome email.Oops! Something went wrong while submitting the form.William C. GendronEditor in ChiefPublishedJuly 27, 2026 3:37 PMUpdatedAugust 24, 2026Join the DiscussionInvestors who purchased or otherwise acquired Zymergen Inc. common stock traceable to the company's April 2021 initial public offering may be eligible to claim a cash payment from a class action settlement.Certain former Zymergen officers and directors, the underwriters of the company's April 2021 IPO and several venture capital firms agreed to pay $125 million to settle a securities class action lawsuit alleging the registration statement and prospectus for the offering contained untrue statements of material fact and omitted material facts.Who can file a claim?The settlement includes all persons and entities who purchased or otherwise acquired Zymergen Inc. common stock between April 21, 2021, and Aug. 3, 2021, inclusive, pursuant or traceable to the registration statement for the company's April 2021 initial public offering.Additional detailsBoth individuals and entities can be class members.Investment vehicles, such as mutual funds, exchange-traded funds, hedge funds, retirement accounts and employee benefit plans, can be class members.The settlement includes shareholders who held stock directly and those who held through a broker or other nominee.Joint claimants must each sign the claim form.Executors and administrators may sign the claim form on behalf of others and must state the capacity in which they are acting.How much can class members get?The total settlement fund is $125,000,000.